Lequememab: A Monoclonal Antibody for Alzheimer's

Lequembe is a monoclonal antibody. It's an inflammatory attack against proteins in your brain, you know what I mean? So inflammation is kind of part of the package here. The estimate is that it will cost per patient per year, 26,500. That's not really affordable.